©2026 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Contributor:

Nancy M. Holekamp, MD

HARBOR Post-Hoc Analysis: Vision Outcomes and the Presence of Fluid
HARBOR Post-Hoc Analysis: Vision Outcomes and the Presence of Fluid

Nancy Holekamp, MD

Think Outside the Box: Treatment Options for DR
Think Outside the Box: Treatment Options for DR

Arshad M. Khanani, MD, Nancy Holekamp, MD, Rishi P. Singh, MD

Reviewing the BOULEVARD Trial and RG7716
Reviewing the BOULEVARD Trial and RG7716

Arshad M. Khanani, MD, Nancy Holekamp, MD, Rishi P. Singh, MD

Anti-VEGF for DR: Implications for Clinical Practice
Anti-VEGF for DR: Implications for Clinical Practice

Arshad M. Khanani, MD, Nancy Holekamp, MD

Changing Treatment Paradigms for DR: Reviewing the Data
Changing Treatment Paradigms for DR: Reviewing the Data

Arshad M. Khanani, MD, Nancy Holekamp, MD

Translating Data for Educating Patients With DR
Translating Data for Educating Patients With DR

Arshad M. Khanani, MD, Nancy Holekamp, MD, Rishi P. Singh, MD

A Provocative AMD Case
A Provocative AMD Case

Nancy Holekamp, MD

A Genetic Association to Anti-VEGF Response?
A Genetic Association to Anti-VEGF Response?

Nancy Holekamp, MD

Preventing Vitreous Liquefaction
Preventing Vitreous Liquefaction

Nancy Holekamp, MD, Ranna Jaraha

Real-World Vision Outcomes in DME Treated with Anti-VEGF Injections - An Analysis of EMR Data from a Large US Health System
Real-World Vision Outcomes in DME Treated with Anti-VEGF Injections - An Analysis of EMR Data from a Large US Health System

Nancy Holekamp MD